Free Trial

Daiichi Sankyo (OTCMKTS:DSNKY) Stock Price Up 0.9% - Should You Buy?

Daiichi Sankyo logo with Medical background

Daiichi Sankyo Company, Limited (OTCMKTS:DSNKY - Get Free Report)'s stock price rose 0.9% during trading on Tuesday . The company traded as high as $24.71 and last traded at $23.91. Approximately 368,177 shares were traded during mid-day trading, an increase of 35% from the average daily volume of 272,974 shares. The stock had previously closed at $23.70.

Daiichi Sankyo Stock Performance

The company has a market cap of $45.63 billion and a PE ratio of 27.80. The company has a debt-to-equity ratio of 0.06, a current ratio of 2.77 and a quick ratio of 2.11. The business has a fifty day simple moving average of $23.94 and a two-hundred day simple moving average of $26.51.

Daiichi Sankyo (OTCMKTS:DSNKY - Get Free Report) last issued its quarterly earnings results on Friday, April 25th. The company reported $0.30 earnings per share for the quarter. The business had revenue of $3.40 billion during the quarter. Daiichi Sankyo had a return on equity of 14.53% and a net margin of 13.62%. Research analysts anticipate that Daiichi Sankyo Company, Limited will post 0.73 earnings per share for the current year.

Daiichi Sankyo Company Profile

(Get Free Report)

Daiichi Sankyo Company, Limited manufactures, markets, and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; ferric carboxymaltose injection for treating anaemia; and Injectafer for the treatment for iron deficiency anaemia.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Daiichi Sankyo Right Now?

Before you consider Daiichi Sankyo, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Daiichi Sankyo wasn't on the list.

While Daiichi Sankyo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

7 Nuclear Stocks One Announcement Away from Exploding
3 AI ETFs for Steady Gains in 2025 (Without the Wild Volatility)
Goldman Sachs Warns of 20% Market Drop—Are They Right?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines